CRISPR Therapeutics AG is a bio-technology company. The Company researches, develops, and manufactures biological transformative gene-based medicines and other related products. CRISPR Therapeutics operates in Switzerland.

Current Report (Form 8-K | Period ending 2024-11-05)

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

CRISPR Therapeutics AG (CRSP US)

Current Report (Form 8-K | Period ending 2024-11-05)

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Quarterly Report (Form 10-Q | Period ending 2024-06-30)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)